Can I Sell in All of Europe With One Approval?

You cannot sell in all of Europe with just one approval. While CE marking provides the foundation for European medical device market access across EU member states, many countries require additional registrations, notifications, or compliance steps beyond basic CE certification. Understanding these requirements helps manufacturers plan efficient market entry strategies across Europe’s complex regulatory landscape.

What Does CE Marking Actually Mean for European Market Access?

CE marking represents a manufacturer’s declaration that their medical device complies with applicable European regulations, primarily the Medical Device Regulation (EU MDR 2017/745). This marking allows placement on the market in all 27 EU member states plus Iceland, Liechtenstein, and Norway through the European Economic Area agreement.

The CE marking process involves several critical steps:

• Device classification according to risk categories – Determines the level of regulatory oversight and conformity assessment procedures required
• Quality management system implementation – Must meet ISO 13485 standards for medical device manufacturing
• Conformity assessment procedures – Higher-risk devices require involvement from notified bodies for independent evaluation
• EUDAMED registration – Devices must be registered in the European database for medical devices
• Technical documentation maintenance – Ongoing compliance demonstration through comprehensive device files

These requirements create a standardized foundation across European markets, but CE marking alone does not guarantee immediate market access everywhere in Europe. Individual countries often impose additional requirements because healthcare systems, reimbursement processes, and national safety monitoring vary significantly across European markets, requiring localized oversight and coordination.

The misconception about “one approval for all of Europe” stems from the harmonized nature of EU medical device regulations. While the core safety and performance requirements are standardized, implementation and oversight remain partially decentralized to national competent authorities.

Which European Countries Require Additional Steps Beyond CE Marking?

Most European countries require some form of additional registration, notification, or compliance step beyond CE marking. These requirements range from simple online notifications to comprehensive dossier submissions with associated fees and review periods.

Key EU country requirements include:

• Germany – Registration with the Federal Institute for Drugs and Medical Devices (BfArM) before market placement
• France – Notification through the ANSM system with specific documentation requirements
• Italy – Registration with the Ministry of Health including device classification verification
• Spain – Notification system through AEMPS with processing timelines varying by device type

Non-EU European countries present additional complexity with independent regulatory frameworks. Switzerland requires Swissmedic registration under its own medical device ordinance, which closely mirrors the EU MDR but operates independently. The United Kingdom, post-Brexit, now requires UKCA marking and MHRA registration for new devices, although CE marking remains temporarily accepted. Norway, despite EEA membership, maintains additional notification requirements through the Norwegian Medicines Agency.

These additional requirements typically involve appointing local representatives, submitting device information in national languages, paying registration fees, and maintaining ongoing compliance reporting. Processing times vary significantly, from immediate online confirmations to several months for complex submissions. Furthermore, some countries require In-Country Representation arrangements in which manufacturers must designate authorized local contacts for regulatory communication.

The rationale behind these requirements includes national pharmacovigilance systems, reimbursement database management, and local market surveillance coordination. Countries need visibility into devices entering their markets to protect patient safety and manage healthcare system resources effectively.

How Do You Actually Navigate the European Regulatory Landscape Efficiently?

Successful European market entry requires strategic planning that prioritizes markets based on commercial potential, regulatory complexity, and resource requirements. Start by identifying your primary target markets and understanding their specific requirements alongside CE marking obligations.

Essential strategies for efficient market access include:

• Phased market entry approach – Begin with markets having simpler notification processes while preparing complex submissions in parallel
• Consolidated representation services – Appoint In-Country Representation providers that handle multiple markets simultaneously
• Standardized documentation packages – Create comprehensive device files adaptable for different national requirements and languages
• Local regulatory partnerships – Establish relationships with consultants who understand specific country procedures and expedite submissions
• Proactive regulatory monitoring – Stay informed about evolving requirements, fees, and processes across target markets
• Integrated timeline planning – Coordinate registration timelines with marketing launches, distributor agreements, and inventory planning

This comprehensive approach allows manufacturers to generate revenue from easier markets while building experience for more challenging jurisdictions. By preparing core documentation upfront and leveraging local expertise, companies can significantly streamline individual country submissions and avoid compliance gaps that could delay market entry or create regulatory issues.

How MedEnvoy Global Helps With European Medical Device Market Access

MedEnvoy Global provides comprehensive solutions for medical device manufacturers seeking efficient access to European markets beyond CE marking requirements. Our specialized services address the complex web of national registrations and compliance requirements that manufacturers face across Europe.

Our approach includes:

• Consolidated In-Country Representation services – Single-point coordination across multiple European jurisdictions reducing administrative complexity
• Streamlined registration processes – Coordinated submissions that minimize timelines and eliminate duplicative efforts
• Local regulatory expertise – Deep knowledge of national requirements, documentation standards, and regulatory communication protocols
• Ongoing compliance monitoring – Proactive regulatory change management and compliance maintenance across target markets
• Strategic market entry planning – Optimized resource allocation and phased approaches that maximize revenue generation potential

Our comprehensive services eliminate the complexity of managing multiple country requirements independently, allowing manufacturers to focus on commercialization while ensuring full regulatory compliance across European markets. By leveraging our established relationships and local expertise, companies can accelerate market entry timelines and reduce the risk of regulatory delays or compliance gaps.

Ready to expand your medical device business across Europe efficiently? Contact MedEnvoy Global today to learn how our comprehensive regulatory services can simplify your path to multiple European markets while ensuring full compliance with national requirements.

Related Articles

• How does Swiss Authorized Representative Designation Impact EU Market Access?
• What Is the Mexico Registration Timeline for Class II Devices?
• How Do I Sell Medical Devices in Spain?
• What Is the Mexican Medical Device Classification System?
• What are the Requirements to Sell Medical Devices in Europe?